Edmond de Rothschild Asset Management (France)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$66.8M Buy
843,750
+476,900
+130% +$38.7M 2.9% 6
2016
Q2
$30.6M Buy
366,850
+9,810
+3% +$871K 1.37% 25
2016
Q1
$32.8M Buy
357,040
+25,650
+8% +$2.31M 1.43% 22
2015
Q4
$33.5M Buy
331,390
+3,100
+0.9% +$323K 1.18% 31
2015
Q3
$32.2M Sell
328,290
-5,000
-2% -$555K 1.06% 36
2015
Q2
$39M Buy
+333,290
New +$36.4M 1.05% 38

Other funds holding GILD

Edmond de Rothschild Asset Management (France)'s GILD Position: Q3 2016 in Review

Edmond de Rothschild Asset Management (France) increased its Gilead Sciences (GILD) stake by 130% in Q3 2016, buying an estimated $38.7M and bringing the position to 843,750 shares worth $66.8M. The position accounts for 2.9% of the portfolio, ranked #6.

Edmond de Rothschild Asset Management (France) first reported a position in GILD in Q2 2015 and has held it in 6 quarters since. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Edmond de Rothschild Asset Management (France) held 843,750 shares of Gilead Sciences worth $66.8M as of Q3 2016.
  • Edmond de Rothschild Asset Management (France) bought 476,900 Gilead Sciences shares in Q3 2016, an estimated $38.7M.
  • Gilead Sciences made up 2.9% of Edmond de Rothschild Asset Management (France)'s portfolio in Q3 2016, its #6 holding.
  • Edmond de Rothschild Asset Management (France) first reported a position in Gilead Sciences in Q2 2015 and has held it in 6 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q3 2016, filed 14 Nov 2016.